Literature DB >> 2068030

Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients.

Y Baruch1, Y Ben-Arie, H Kerner, M Lorber, L A Best, R Gershoni-Baruch.   

Abstract

We report on 8 patients with giant lymph node hyperplasia (GLNH), diagnosed over a 10-year period. The age of the patients at diagnosis, the clinical presentation and the histological subtype varied, indicating that GNLH is a heterogeneous condition. One case was associated with liver cirrhosis, and in another patient bacterial endocarditis was diagnosed post mortem. Our study shows that GLNH is localized and benign in the young, and diffuse and aggressive in the elderly. It is concluded that GLNH should be separated into 3 clinical entities--namely, localized, systemic and reactive GLNH--defined by their clinical presentation and course, and correlated or not correlated with the histological findings.

Entities:  

Mesh:

Year:  1991        PMID: 2068030      PMCID: PMC2398791          DOI: 10.1136/pgmj.67.786.366

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  23 in total

1.  Letter: The use of psychological test data to predict open-heart surgery outcome.

Authors:  R M Factor
Journal:  Psychosom Med       Date:  1975 Nov-Dec       Impact factor: 4.312

2.  REFRACTORY ANEMIA WITH ABNORMAL IRON METABOLISM: ITS REMISSION AFTER RESECTION OF HYPERPLASTIC MEDIASTINAL LYMPH NODES.

Authors:  S L LEE; F ROSNER; I RIVERO; F FELDMAN; A HURWITZ
Journal:  N Engl J Med       Date:  1965-04-15       Impact factor: 91.245

3.  Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases.

Authors:  D D Weisenburger; B N Nathwani; C D Winberg; H Rappaport
Journal:  Hum Pathol       Date:  1985-02       Impact factor: 3.466

4.  Giant lymph node hyperplasia of the hyaline vascular type with plasmacytoid T-cells and presentation in infancy.

Authors:  S J Hunt; W D Anderson
Journal:  Am J Clin Pathol       Date:  1989-03       Impact factor: 2.493

5.  Castleman's disease: more questions than answers.

Authors:  G Frizzera
Journal:  Hum Pathol       Date:  1985-03       Impact factor: 3.466

6.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

7.  Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis.

Authors:  H E Emson
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

8.  Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura.

Authors:  W D Couch
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

9.  Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS).

Authors:  N A Lachant; N C Sun; L A Leong; R S Oseas; H E Prince
Journal:  Am J Clin Pathol       Date:  1985-01       Impact factor: 2.493

10.  Gastric Castleman's disease with a lupus-like circulating anticoagulant.

Authors:  M Yebra; J A Vargas; M J Menéndez; J R Cabrera; F Díaz; F J Diego; A Durántez
Journal:  Am J Gastroenterol       Date:  1989-05       Impact factor: 10.864

View more
  2 in total

Review 1.  Portal hypertension and refractory ascites associated with multicentric Castleman's disease.

Authors:  M Abarca; R J Andrade; A García-Arjona; J L Escolar; A Blanes; J M García-Hirschfeld; P González-Santos
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Liver cirrhosis in a child associated with Castleman's disease: A case report.

Authors:  Soya Kobayashi; Ayano Inui; Tomoyuki Tsunoda; Syuichiro Umetsu; Tsuyoshi Sogo; Masaaki Mori; Masato Shinkai; Tomoo Fujisawa
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.